TY - JOUR ID - 87868 TI - Medical Cost to Treat Cervical Cancer Patients at a Social Security Third Level Oncology Hospital in Mexico City JO - Asian Pacific Journal of Cancer Prevention JA - APJCP LA - en SN - 1513-7368 AU - Granados-García, Víctor AU - Piña-Sánchez, Patricia AU - Reynoso-Noveron, Nancy AU - Flores, Yvonne N AU - Toledano-Toledano, Filiberto AU - Estrada-Gómez, Gloria AU - Apresa-García, Teresa AU - Briseño, Arely A AD - Epidemiological and Health Services Research Unit. Aging Area, 21st Century National Medical Center. Mexican Institute of Social Security (IMSS). Mexico City, Mexico. AD - Unit of Medical Research in Oncological Diseases, UMAE, Oncology Hospital, 21st Century National Medical Center, IMSS. Mexico City, Mexico. AD - Research Directorate, National Institute of Cancerology. Mexico City, Mexico. AD - Epidemiological and Health Services Research Unit, Morelos Delegation, IMSS. Cuernavaca Morelos, Mexico. AD - Evidence-Based Medicine Research Unit. Children’s Hospital of Mexico Federico Gómez, National Institute of Health. Mexico City, Mexico. Y1 - 2019 PY - 2019 VL - 20 IS - 5 SP - 1547 EP - 1554 KW - Treatment costs KW - Cost analysis KW - Cervical cancer KW - Mexico DO - 10.31557/APJCP.2019.20.5.1547 N2 - Background: Cervical Cancer (CC) is an important public health problem worldwide. In 2015, CC was the sixthleading cause of death for women aged 30-59 years in Mexico. Despite the importance of having high-quality andaccurate estimates of CC treatment costs that can be used to effectively evaluate the impact of preventive programs, thereis scarce information on this topic in Mexico. Objective: To estimate the treatment costs by stage diagnosis in patientswith CC at a Mexican Social Security Institute (IMSS) oncology hospital in Mexico City. Methods: An observationalretrospective study of the resources used to treat 346 women with CC was conducted. Medical charts were reviewed andrelevant resource use information was extracted using a data collection instrument that was created based on treatmentguidelines. Data were classified into nine cost categories to estimate the total cost per patient. Results: The mean ageof patients in the study sample was 54.3 years (range: 41-67), and the average body mass index (BMI) was >26 kg/m2.Among the participants, 37% were smokers, 39% had diabetes, and 56% had hypertension. The medical cost for stagesI-IV ranged from $4,738 to $6,058 USD, with an estimated average cost of $5,114 USD. Conclusion: Total treatmentcosts per patient are high, especially since they were estimated considering only 7.5 months of treatment. This is thefirst study to estimate the annual cost to treat CC in Mexico and to additionally document the resource pattern use, costby stage of cancer, and the distribution by cost categories. UR - https://journal.waocp.org/article_87868.html L1 - https://journal.waocp.org/article_87868_403d900e6ddc340cb1e6c701b14704d2.pdf ER -